Previous studies suggest potential roles of GLYAT family members in various cancers, for instance, aberrant GLYAT expression has been associated with hepatocellular carcinomas and breast cancer [12], and reduced GLYATL1 expression is correlated with short overall survival in hepatocellular carcinoma patients [13]. This evidence concerns the gene GLYAT and breast carcinoma.